NIAID Releases Strategic Plan for Tuberculosis Research
TB is the world’s leading infectious cause of death. In its new strategic plan, NIAID details five strategic priorities for building on research advances to develop the knowledge and tools to end TB globally.
Early-Stage Ebola Treatment Trial Begins
NIAID scientists are evaluating a monoclonal antibody treatment for Ebola in a Phase 1 clinical trial at the NIH Clinical Center.
New DAIDS Regulatory Support Center Site
The DAIDS Regulatory Support Center (RSC) site has been redesigned. The DAIDS RSC website provides information on regulatory aspects of DAIDS clinical trial operations.